MAPK1 (ERK2) activation
REACTOME PATHWAYThe MAPK1 (ERK2) activation pathway (Reactome ID: R-HSA-112411) involves 5 genes and is affected by 43 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting MAPK1 (ERK2) activation
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | pd98059 | — | 7 |
| 2 | sp600125 | — | 117 |
| 3 | trametinib | — | 296 |
| 4 | Dasatinib | — | 299 |
| 5 | Axitinib | — | 298 |
| 6 | plumbagin [Supplementary Concept] | — | 300 |
| 7 | tyrphostin ag 1478 | — | 4 |
| 8 | alsterpaullone | — | 12 |
| 9 | kenpaullone | — | 8 |
| 10 | Clotrimazole | — | 296 |
| 11 | fisetin | — | 78 |
| 12 | Progesterone | — | 299 |
| 13 | 2-Chloroadenosine 2-Chloroadenosine. | — | 300 |
| 14 | Benzalkonium Compounds | — | 299 |
| 15 | Calcimycin | — | 216 |
| 16 | daph | — | 2 |
| 17 | Diphenhydramine | — | 14 |
| 18 | ha1004 | — | 4 |
| 19 | isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from | — | 300 |
| 20 | Lithocholic Acid | — | 300 |
| 21 | Loratadine | — | 296 |
| 22 | Sorafenib | — | 300 |
| 23 | trequinsin hydrochloride | — | 1 |
| 24 | withaferin | — | 300 |
| 25 | Azauridine | — | 300 |
| 26 | Cladribine | — | 297 |
| 27 | Methylene Blue | — | 200 |
| 28 | 2-Methoxyestradiol | — | 300 |
| 29 | Astemizole Antihistamine drug now withdrawn from | — | 280 |
| 30 | Azathioprine | — | 300 |
| 31 | Calcitriol | — | 300 |
| 32 | Camptothecin | — | 300 |
| 33 | Cytarabine | — | 297 |
| 34 | dihydrorotenone | — | 13 |
| 35 | Podophyllotoxin | — | 14 |
| 36 | streptonigrin | — | 299 |
| 37 | Trifluridine | — | 295 |
| 38 | Tripterygium | — | 300 |
| 39 | Crizotinib | — | 298 |
| 40 | Methotrexate | — | 289 |
| 41 | pictilisib | — | 25 |
| 42 | Vemurafenib | — | 298 |
| 43 | Prednisolone | — | 1,000 |
About the MAPK1 (ERK2) activation Pathway
The MAPK1 (ERK2) activation pathway is catalogued in Reactome (ID: R-HSA-112411) and involves 5 genes. In the BiohacksAI corpus, 43 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include IL6, JAK2, MAP2K2, MAPK1, TYK2.